HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Clinical trial NCT05535933 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05535933
- Sponsor
- Hutchmed
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2025-11-25
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.